Estimating Transition Probabilities for Modeling Major Depression in Adolescents by Sex and Race or Ethnicity Combinations in the USA
ConclusionsThis study validated new transition probabilities for future use in decision models evaluating adolescent  depression policies or interventions. Different sets of transition parameters by demographic factors (sex and race or ethnicity combinations) were generated to support future health equity research, including distributional cost-effectiveness analysis. Further data disaggregated with respect to ra ce, ethnicity, religion, income, geography, gender identity, sexual orientation, and disability would be helpful to project accurate estimates for historically minoritized communities. (Source: Applied Health Ec...
Source: Applied Health Economics and Health Policy - January 22, 2024 Category: Health Management Source Type: research

Are Web-Based Valuation Surveys for Preference-Based Measures as Reliable as Face-to-Face Surveys? TTO, DCE and DCE with Duration
ConclusionIf the face-to-face cTTO score is the gold standard, a web-based survey of cTTO is not recommended regardless of the ICC. If a DCE survey is performed, positioning effects should be considered. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - January 13, 2024 Category: Health Management Source Type: research

A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries
ConclusionsMost analysed countries show a trend towards value-based approaches that consider value for money to society, but also other economic, clinical, and humanistic criteria. Good practices included robustness, transparency, independence, and participation. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - January 12, 2024 Category: Health Management Source Type: research

Correction: Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL-SELF Trial of Patient-Led Melanoma Surveillance
(Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - January 12, 2024 Category: Health Management Source Type: research

Do Informal Care Recipients Internalise Carer Burden? Examining the Impact of Informal Care Receipt on Health Behaviours
ConclusionsThe asymmetric effects detected suggest that the underlying mechanisms are different, and care recipients may be engaging in risk and effort compensation between negative and positive health behaviours. Failure to account for the behavioural responses from informal care recipients may lead to under-estimation or over-estimation of the extent of caregiving burden and the effectiveness of interventions impacting informal carers. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - January 10, 2024 Category: Health Management Source Type: research

Cost-Effectiveness Analysis of Systemic Therapy for Intensification of Treatment in Metastatic Hormone-Sensitive Prostate Cancer in India
ConclusionsWe concur with the inclusion of standard-dose AAP in India ’s publicly financed health insurance scheme for the intensification of treatment in mHSPC as it is the only cost-effective sequence among the various novel anti-androgens when compared with the docetaxel-first treatment sequence. Furthermore, a systematic reduction in the price of enzalutamide wo uld further help to improve clinical outcomes among patients with mHSPC. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - January 10, 2024 Category: Health Management Source Type: research

The Limitations and Potentials of Evaluating Economic Aspects of Community-Based Health Promotion: A Critical Review
AbstractCommunity-based health promotion (CBHP) interventions are promising approaches to address public health problems; however, their economic evaluation presents unique challenges. This review aims to explore the opportunities and limitations of evaluating economic aspects of CBHP, focusing on the assessment of intervention costs and outcomes, and the consideration of political-level changes and health equity. A systematic search of the PubMed, Web of Science and PsycInfo databases identified 24 CBHP interventions, the majority of which targeted disadvantaged communities. Only five interventions included a detailed cos...
Source: Applied Health Economics and Health Policy - January 8, 2024 Category: Health Management Source Type: research

Comment on: “Adding Value to CHEERS: New Reporting Standards for Value of Information Analyses”
(Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - December 23, 2023 Category: Health Management Source Type: research

An Optional Delinked Reward System: Making Pharmaceutical Innovation Work for Everyone
AbstractConflicts over pharmaceutical pricing are driven by the patients ’ need for affordable medicines and the producer’s reward for the investments in developing innovative medicines. A single price cannot achieve both goals, as it will either obstruct access by patients or provide too low a return to investors. This has led to calls to “delink” the payment fo r innovation from the price paid for drugs, so that both goals can be met efficiently and without conflict. However, the details of how best to do that are unclear. This paper proposes a specific implementation for delinking the Optional Delinked Reward Sy...
Source: Applied Health Economics and Health Policy - December 22, 2023 Category: Health Management Source Type: research

Treatment Preferences of Adolescents and Young Adults with Depressive Symptoms: A Discrete Choice Experiment
ConclusionIn this DCE, three classes could be identified that share similar preferences regarding treatment effectiveness, waiting time and evaluation of the therapeutic alliance, but varied considerably in their preference for treatment type (individual, group, or combined psychotherapy) and their willingness to engage. The results from this study may inform mental health care providers and institutions and help optimize professional care for adolescents and young adults with depressive symptoms, improving engagement in this vulnerable group. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - December 18, 2023 Category: Health Management Source Type: research

Acknowledgement to Referees
(Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - December 18, 2023 Category: Health Management Source Type: research

Participatory Value Evaluation (PVE): A New Preference-Elicitation Method for Decision Making in Healthcare
AbstractParticipatory value evaluation (PVE) has recently been introduced in the field of health as a new method to elicit stated preferences for public policies. PVE is a method in which respondents in a choice experiment are presented with various policy options and their attributes, and are asked to compose their portfolio of preference given a public-resource constraint. This paper aims to illustrate PVE ’s potential for informing healthcare decision making and to position it relative to established preference-elicitation methods. We first describe PVE and its theoretical background. Next, by means of a narrative rev...
Source: Applied Health Economics and Health Policy - December 16, 2023 Category: Health Management Source Type: research

Correction to: Different Frameworks, Similar Results? Head-to-Head Comparison of the Generic Preference-Based Health-Outcome Measures CS-Base and EQ-5D-5L
(Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - December 16, 2023 Category: Health Management Source Type: research

Should Commercial Diagnostic Testing Be Stimulated or Discouraged? Analyzing Willingness-to-Pay and Market Externalities of Three Commercial Diagnostic Tests in The Netherlands
ConclusionMost respondents were unwilling to consume CDT at any price or only if the CDT were provided for free. However, for a small group of consumers, societal costs exceed private benefits. Therefore, CDT regulation could provide small welfare gains. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - December 15, 2023 Category: Health Management Source Type: research

Comment on: “10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?”
(Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - December 2, 2023 Category: Health Management Source Type: research